New GSK general manager named amid bribery probe in China

07/26/2013 | New York Times (tiered subscription model), The

GlaxoSmithKline, which is the focus of an ongoing bribery investigation in China, Has named Herve Gisserot to replace Mark Reilly as general manager in China. "He's effective immediately head of the China business, and this is part of our attempt to strengthen our China management team and ensure we can support our customers in China, as well as with the ongoing investigation," a company spokesman said.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI